DACLERAD Trademark

Trademark Overview

On Thursday, December 8, 2016, a trademark application was filed for DACLERAD with the United States Patent and Trademark Office. The USPTO has given the DACLERAD trademark a serial number of 87262244. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 18, 2021. This trademark is owned by Bristol-Myers Squibb Company. The DACLERAD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
daclerad

General Information

Serial Number87262244
Word MarkDACLERAD
Filing DateThursday, December 8, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 18, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 17, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 13, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Tuesday, January 19, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 18, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, July 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 30, 2020EXTENSION 5 GRANTED
Friday, June 12, 2020EXTENSION 5 FILED
Monday, June 29, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 12, 2020TEAS EXTENSION RECEIVED
Saturday, December 14, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 12, 2019EXTENSION 4 GRANTED
Thursday, December 12, 2019EXTENSION 4 FILED
Thursday, December 12, 2019TEAS EXTENSION RECEIVED
Wednesday, July 17, 2019ASSIGNED TO EXAMINER
Wednesday, June 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 10, 2019EXTENSION 3 GRANTED
Monday, June 10, 2019EXTENSION 3 FILED
Monday, June 10, 2019TEAS EXTENSION RECEIVED
Friday, December 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 5, 2018EXTENSION 2 GRANTED
Wednesday, December 5, 2018EXTENSION 2 FILED
Wednesday, December 5, 2018TEAS EXTENSION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 21, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 21, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 11, 2018EXTENSION 1 GRANTED
Monday, June 11, 2018EXTENSION 1 FILED
Monday, June 11, 2018TEAS EXTENSION RECEIVED
Tuesday, December 12, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 17, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 27, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 1, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 31, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 30, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 30, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 6, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 6, 2017NON-FINAL ACTION E-MAILED
Monday, March 6, 2017NON-FINAL ACTION WRITTEN
Monday, February 27, 2017ASSIGNED TO EXAMINER
Tuesday, December 13, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 12, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

daclerad diseases pharmaceutical human anti preparations disorders organ solid auto immune